As of June 12 in Massachusetts, there have been 3,791 people fully vaccinated for COVID-19 who have tested positive for the virus.
According to the Massachusetts Department of Public Health, these breakthrough cases make up 0.1 percent of the 3,720,037 fully vaccinated people in the state, the Boston Herald reported.
“Testing to identify current infection remains critical to control of COVID-19,” a DPH spokeswoman told the paper. “People with current infection can spread the virus to others and isolation of cases and identification of close contacts (individuals who may have been exposed) is a foundation of public health response.”
Health officials also warned about the contagious “Delta variant,” seen in some areas in the United States. Todd Ellerin, director of infectious diseases at South Shore Health, expressed the need to get as many people vaccinated due to the highly contagious variants.
Boston University infectious diseases specialist Davidson Hamer noted, “We’re learning that many of the breakthrough infections are asymptomatic or they’re very mild and brief in duration. The viral load is not very high.”
“Breakthroughs are expected, and we need to better understand who’s at risk and whether people who have a breakthrough can transmit the virus to others,” Hamer added. “In some cases, they’ll be shedding such low levels of the virus and won’t be transmitting to others.”
The phenomenon of “shedding,” or transmission of the spike protein from people inoculated with mRNA vaccines to unvaccinated people, has been dubbed “the latest COVID-19 vaccine misinformation,” and “fact checked” as having “no scientific basis.” But in reality, it does happen.
Writes Dr. Lee D. Merritt,
Recently, a paper written by the FDA in 2015 surfaced, titled “Design and Analysis of Shedding Studies for Virus or Bacteria-Based Gene Therapy and Oncolytic Products — Guidance for Industry.” The paper, which was written for pharmaceutical researchers, states in the introduction, “Shedding raises the possibility of transmission of VBGT or oncolytic products from treated to untreated individuals (e.g., close contacts and healthcare professionals).”
Dr. Merritt says the FDA suggests pre-clinical data on shedding may be requested if “humans have not been previously exposed to the product and the route of administration differs from the natural route of exposure /infection,” which certainly applies to the COVID shots. It is noted that the FDA recommends these studies be done prior to licensure, specifically in Stage I testing. Currently, America, and the whole world, is now at Phase IV of the vaccine-approval process, but no official information on shedding is provided.
In the meantime, the Centers for Disease Control and Prevention (CDC) pacifies the public, saying breakthrough cases are normal. “COVID-19 vaccines are effective and are a critical tool to bring the pandemic under control. However, no vaccines are 100 percent effective at preventing illness. There will be a small percentage of people who are fully vaccinated who still get sick, are hospitalized, or die from COVID-19,” states the agency.
The CDC said last month that through April 30, 10,262 breakthrough infections were reported from 46 U.S. states and territories to the agency. Of the cases, more than six in 10 occurred in females, with the median patient age being 58, according to a new report from the CDC, which stopped counting breakthrough infections as of May 1, except for those that cause hospitalization or death. Approximately 10 percent of the patients required hospital care, and 160, or about 1.5 percent, died.
“Part of what’s at play here is that each person’s immune response to a vaccine will be different, in the same way that each person’s response to contracting COVID-19 has been different,” says Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia.
He says it is also important to consider that a virus’s incubation period, or the time between a person being infected with the virus and when that person shows symptoms, can vary widely between viruses. The shorter the incubation period, the more the virus is able to spread before the body’s immune response gets going.
But all these factors, indeed, should have been evaluated during the medical trials. According to John Hopkins University, a typical vaccine development timeline takes five to 10 years, and sometimes longer, to assess whether the vaccine is safe and efficacious in clinical trials, complete the regulatory approval processes, and manufacture sufficient quantity of vaccine doses for widespread distribution. But due to “pandemic and urgent need,” the timeline for COVID-19 vaccines was accelerated. The CDC claims it did not affect their safety and efficacy, and recommends them to adolescents, and “pregnant or breastfeeding people” (yes, the CDC uses a “woke” language to refer to mothers-to-be and breastfeeding women), even though “there are currently limited data on the safety of COVID-19 vaccines in pregnant people,” and “Clinical trials for the COVID-19 vaccines … did not include people who are breastfeeding.”
The concerns over vaccines’ safety are constantly resurfacing, but all those “unfortunate” cases of deaths and severe side effects, and now COVID-19 infections, are shrugged off by the “expert” community and mainstream media as “statistical errors” that “are expected.”
According to the CDC, 317 million doses of COVID-19 vaccine have been given in the United States from December 14, 2020, through June 21, 2021.
President Biden declared June a “national month of action” and introduced a slew of incentives to vaccinate 70 percent of Americans by the Fourth of July.
The world’s biggest genetic experiment on the population continues.
